Prostatic Neoplasms: all 6,484 studies

Page 24 of 65. Open to participants first (1,413), then studies with results posted, then the rest; newest registration first within each.

• Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate CancerCompletedNCT00669162Phase 1/2Results posted
• Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate CancerCompletedNCT00668642Phase 2Results posted
• A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationStatus unknownNCT00667888Phase 3Results posted
• Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate CancerCompletedNCT00667862Phase 2Results posted
• Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsCompletedNCT00666926Phase 1Results posted
• R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate CancerCompletedNCT00666666Phase 2Results posted
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)CompletedNCT00661492Phase 2Results posted
• Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate CancerCompletedNCT00659438Phase 2Results posted
• Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate CancerCompletedNCT00658697Phase 2Results posted
• Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC PatientsCompletedNCT00654186Phase 2Results posted
• CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionCompletedNCT00643994Not applicableResults posted
• CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryCompletedNCT00643617Not applicableResults posted
• A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate CancerCompletedNCT00642018Phase 2Results posted
• Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT00638690Phase 3Results posted
• Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate CancerTerminatedNCT00638378Phase 2Results posted
• Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)TerminatedNCT00635167Not applicableResults posted
• Satraplatin and Prednisone to Treat Prostate CancerCompletedNCT00634647Phase 2Results posted
• Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone MetastasesTerminatedNCT00634582Phase 2Results posted
• A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate CancerTerminatedNCT00633087Phase 1/2Results posted
• RAD001 and Bicalutamide for Androgen Independent Prostate CancerCompletedNCT00630344Phase 2Results posted
• RAD001 in Patients With Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00629525Phase 2Results posted
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerTerminatedNCT00626548Phase 3Results posted
• A Study of Leuprolide to Treat Prostate CancerCompletedNCT00626431Phase 3Results posted
• Stereotactic Radiation Therapy in Treating Patients With Prostate CancerTerminatedNCT00619515Not applicableResults posted
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerCompletedNCT00617669Phase 3Results posted
• Phase II Sunitinib Prog Met AIPCCompletedNCT00599313Phase 2Results posted
• Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerCompletedNCT00589472Phase 2Results posted
• Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00589420Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate CancerCompletedNCT00587431Phase 2Results posted
• Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's CycleCompletedNCT00586898Phase 2Results posted
• Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21CompletedNCT00583752Phase 2Results posted
• Randomized Trial of Suicide Gene Therapy and Prostate CancerCompletedNCT00583492Phase 2Results posted
• Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate CancerCompletedNCT00583024Phase 2Results posted
• Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation TherapyCompletedNCT00582556Phase 2Results posted
• Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal InjuryCompletedNCT00580970Phase 2Results posted
• Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate CancerTerminatedNCT00577356Phase 2Results posted
• Internal Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00573833Not applicableResults posted
• Statin Therapy Versus Placebo Prior to ProstatectomyCompletedNCT00572468Not applicableResults posted
• Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate CancerCompletedNCT00570700Phase 2Results posted
• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerActive, not recruitingNCT00567580Phase 3Results posted
• FACBC PET/CT for Recurrent Prostate CancerCompletedNCT00562315Phase 2Results posted
• ARTS - AVODART After Radical Therapy For Prostate Cancer StudyCompletedNCT00558363Phase 2Results posted
• Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseCompletedNCT00558272Phase 2Results posted
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesCompletedNCT00554229Phase 3Results posted
• Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerCompletedNCT00551525Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00547339Phase 1/2Results posted
• Vinflunine in Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00545766Phase 2Results posted
• An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow PlasmaCompletedNCT00544440Phase 2Results posted
• ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate CancerTerminatedNCT00544076Phase 3Results posted
• An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate CancerCompletedNCT00537381Phase 2Results posted
• Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerTerminatedNCT00536991Phase 1/2Results posted
• Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyCompletedNCT00528866Phase 2Results posted
• Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00527124Phase 2Results posted
• Everolimus in Treating Patients With Newly Diagnosed Localized Prostate CancerTerminatedNCT00526591Phase 2Results posted
• Vitamin D in Treating Patients With Prostate CancerCompletedNCT00524680Phase 2Results posted
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00524589Phase 2Results posted
• Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate CancerCompletedNCT00520546Phase 3Results posted
• Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerCompletedNCT00520481Phase 2Results posted
• Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerCompletedNCT00519285Phase 3Results posted
• Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate CancerTerminatedNCT00515112Phase 2Results posted
• A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)TerminatedNCT00514917Phase 3Results posted
• Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate CancerCompletedNCT00514540Phase 2Results posted
• AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00513071Phase 2Results posted
• A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerCompletedNCT00510718Phase 1Results posted
• Sandostatin for Patients With Androgen Independent Prostate CancerTerminatedNCT00510224Phase 2Results posted
• A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer PatientsTerminatedNCT00503984Phase 1/2Results posted
• Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedNCT00500110Phase 2Results posted
• Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With DocetaxelCompletedNCT00499694Not applicableResults posted
• Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerCompletedNCT00499408Phase 2Results posted
• Observation or Radical Treatment in Patients With Prostate CancerTerminatedNCT00499174Not applicableResults posted
• E3-Hormone Refractory Prostrate Cancer Taxotere CombinationCompletedNCT00498797Phase 2Results posted
• Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00488982Phase 2Results posted
• The Effect of High-dose Silybin-phytosome in Men With Prostate CancerCompletedNCT00487721Phase 2Results posted
• Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00486642Phase 2Results posted
• An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyCompletedNCT00485303Phase 2Results posted
• Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00483561Phase 2Results posted
• Docetaxel in Treating Patients With Relapsed Prostate CancerTerminatedNCT00482274Phase 2Results posted
• Salvage Radiation Therapy and Taxotere for PSA Failure After Radical ProstatectomyTerminatedNCT00480857Phase 2Results posted
• Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerTerminatedNCT00477087Phase 2Results posted
• Fulvestrant in Hormone Refractory Prostate CancerCompletedNCT00476645Phase 2Results posted
• Effect of Weight Loss on Prostate Cancer PathologyCompletedNCT00475982Not applicableResults posted
• An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyCompletedNCT00474383Phase 2Results posted
• Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate CancerCompletedNCT00473746Phase 1/2Results posted
• A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone TherapyCompletedNCT00473512Phase 1/2Results posted
• ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00471718Phase 1/2Results posted
• Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyCompletedNCT00470834Phase 4Results posted
• Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation TherapyCompletedNCT00468286Phase 2Results posted
• Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate CancerCompletedNCT00466752Phase 2Results posted
• A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsCompletedNCT00466440Phase 2Results posted
• Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing RadiotherapyCompletedNCT00462124Not applicableResults posted
• Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00460031Phase 2Results posted
• Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate CancerTerminatedNCT00459810Phase 2Results posted
• The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerCompletedNCT00459186Phase 1/2Results posted
• Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate CancerCompletedNCT00456989Phase 1/2Results posted
• Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate CancerCompletedNCT00454571Phase 2Results posted
• Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)TerminatedNCT00452387Phase 2Results posted
• A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyCompletedNCT00451958Phase 3Results posted
• Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate CancerCompletedNCT00450749Phase 2Results posted
• 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate CancerCompletedNCT00450619Phase 2Results posted

← Prostatic Neoplasms overview